Loading data for BCYC — first visit, this takes a few seconds.
Bicycle Therapeutics (BCYC)
NasdaqGS: BCYC
· 실시간 가격 · USD
4.12
+0.13 (3.26%)
종가 기준: Aug 14, 2026, 8:00 PM
Bicycle Therapeutics (BCYC) Stock Price, Analysis & Data
3.26% (1D)
데이터 없음
BCYC 소개
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clin...
전체 기업 정보재무 실적
2025년 Bicycle Therapeutics의 매출은 72.59M로, 전년 35.27M 대비 105.77% 증가했습니다. 순이익은 -218.96M로, 29.54% 증가했습니다.
재무제표어닝 서프라이즈
Bicycle Therapeutics가 Jul 30, 2026에 분기 실적을 발표했습니다:
2 페이지 중 1
